{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T03:46:46Z","timestamp":1793072806659,"version":"4.5.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,5,28]],"date-time":"2014-05-28T00:00:00Z","timestamp":1401235200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.ajpath.2014.03.006","type":"journal-article","created":{"date-parts":[[2014,6,18]],"date-time":"2014-06-18T22:17:44Z","timestamp":1403129864000},"page":"2099-2110","source":"Crossref","is-referenced-by-count":100,"title":["Hypercholesterolemia Induces Angiogenesis and Accelerates Growth of Breast Tumors in\u00a0Vivo"],"prefix":"10.1016","volume":"184","author":[{"given":"Kristine","family":"Pelton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine M.","family":"Coticchia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam S.","family":"Curatolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl P.","family":"Schaffner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Zurakowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith R.","family":"Solomon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marsha A.","family":"Moses","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpath.2014.03.006_bib1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ajpath.2014.03.006_bib2","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/bjc.1991.210","article-title":"Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County","volume":"63","author":"Shimizu","year":"1991","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ajpath.2014.03.006_bib3","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S0140-6736(03)13913-X","article-title":"Are imprecise methods obscuring a relation between fat and breast cancer?","volume":"362","author":"Bingham","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ajpath.2014.03.006_bib4","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s10549-009-0603-y","article-title":"Metabolic profile, physical activity, and mortality in breast cancer patients","volume":"121","author":"Emaus","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ajpath.2014.03.006_bib5","doi-asserted-by":"crossref","first-page":"332","DOI":"10.3923\/pjbs.2009.332.338","article-title":"Serum lipid profile of breast cancer patients","volume":"12","author":"Owiredu","year":"2009","journal-title":"Pak J Biol Sci"},{"key":"10.1016\/j.ajpath.2014.03.006_bib6","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1001\/jama.296.2.193","article-title":"Adult weight change and risk of postmenopausal breast cancer","volume":"296","author":"Eliassen","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.ajpath.2014.03.006_bib7","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1126\/science.290.5497.1721","article-title":"How cells handle cholesterol","volume":"290","author":"Simons","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.ajpath.2014.03.006_bib8","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1161\/01.ATV.0000131264.66417.d5","article-title":"Intracellular cholesterol transport","volume":"24","author":"Soccio","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ajpath.2014.03.006_bib9","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.coph.2012.07.009","article-title":"Cholesterol and breast cancer development","volume":"12","author":"Danilo","year":"2012","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.ajpath.2014.03.006_bib10","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1038\/sj.bjc.6600267","article-title":"Statin use, hyperlipidaemia, and the risk of breast cancer","volume":"86","author":"Kaye","year":"2002","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ajpath.2014.03.006_bib11","doi-asserted-by":"crossref","first-page":"348","DOI":"10.2165\/00003088-199631050-00003","article-title":"Clinical pharmacokinetics of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors","volume":"31","author":"Desager","year":"1996","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.ajpath.2014.03.006_bib12","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1002\/cncr.20271","article-title":"The association between 3-hydroxy-3-methylglutaryl coenzyme A inhibitor use and breast carcinoma risk among postmenopausal women: a case-control study","volume":"100","author":"Boudreau","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.ajpath.2014.03.006_bib13","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1093\/jnci\/djj188","article-title":"Statin use and breast cancer: prospective results from the Women's Health Initiative","volume":"98","author":"Cauley","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ajpath.2014.03.006_bib14","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/CEJ.0b013e3283354918","article-title":"Serum cholesterol level, use of a cholesterol-lowering drug, and breast cancer: results from the prospective E3N cohort","volume":"19","author":"Fagherazzi","year":"2010","journal-title":"Eur J Cancer Prev"},{"key":"10.1016\/j.ajpath.2014.03.006_bib15","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1089\/154099903322447710","article-title":"Lipid-lowering drug use and breast cancer in older women: a prospective study","volume":"12","author":"Cauley","year":"2003","journal-title":"J Womens Health (Larchmt)"},{"key":"10.1016\/j.ajpath.2014.03.006_bib16","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1158\/1055-9965.EPI-07-0726","article-title":"Estrogen receptor-negative breast cancer is less likely to arise among lipophilic statin users","volume":"17","author":"Kumar","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ajpath.2014.03.006_bib17","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1158\/0008-5472.CAN-10-2953","article-title":"Long-term use of cholesterol-lowering drugs and cancer incidence in a large United States cohort","volume":"71","author":"Jacobs","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2014.03.006_bib18","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1200\/JCO.2010.31.5200","article-title":"Total cholesterol and cancer risk in a large prospective study in Korea","volume":"29","author":"Kitahara","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ajpath.2014.03.006_bib19","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1093\/jnci\/djr291","article-title":"Statin prescriptions and breast cancer recurrence risk: a Danish nationwide prospective cohort study","volume":"103","author":"Ahern","year":"2011","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ajpath.2014.03.006_bib20","doi-asserted-by":"crossref","first-page":"585","DOI":"10.3109\/07357907.2011.616252","article-title":"Reduced risk of breast cancer recurrence in patients using ACE inhibitors, ARBs, and\/or statins","volume":"29","author":"Chae","year":"2011","journal-title":"Cancer Invest"},{"key":"10.1016\/j.ajpath.2014.03.006_bib21","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s10549-007-9683-8","article-title":"Post-diagnosis statin use and breast cancer recurrence in a prospective cohort study of early stage breast cancer survivors","volume":"109","author":"Kwan","year":"2008","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ajpath.2014.03.006_bib22","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.tem.2007.12.004","article-title":"Do the cholesterol-lowering properties of statins affect cancer risk?","volume":"19","author":"Solomon","year":"2008","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.ajpath.2014.03.006_bib23","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.2353\/ajpath.2009.080551","article-title":"Ezetimibe is an inhibitor of tumor angiogenesis","volume":"174","author":"Solomon","year":"2009","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2014.03.006_bib24","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1172\/JCI200519935","article-title":"Cholesterol targeting alters lipid raft composition and cell survival in prostate cancer cells and xenografts","volume":"115","author":"Zhuang","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajpath.2014.03.006_bib25","doi-asserted-by":"crossref","first-page":"e30062","DOI":"10.1371\/journal.pone.0030062","article-title":"Impact of circulating cholesterol levels on growth and intratumoral androgen concentration of prostate tumors","volume":"7","author":"Mostaghel","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ajpath.2014.03.006_bib26","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.ajpath.2010.11.005","article-title":"Role of cholesterol in the development and progression of breast cancer","volume":"178","author":"Llaverias","year":"2011","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2014.03.006_bib27","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1038\/onc.2012.113","article-title":"Mammary tumor growth and pulmonary metastasis are enhanced in a hyperlipidemic mouse model","volume":"32","author":"Alikhani","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.ajpath.2014.03.006_bib28","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1073\/pnas.0810617106","article-title":"Lipocalin 2 promotes breast cancer progression","volume":"106","author":"Yang","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2014.03.006_bib29","doi-asserted-by":"crossref","first-page":"20758","DOI":"10.1074\/jbc.M110.216036","article-title":"ADAM12 transmembrane and secreted isoforms promote breast tumor growth: a distinct role for ADAM12-S protein in tumor metastasis","volume":"286","author":"Roy","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2014.03.006_bib30","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.mvr.2005.11.007","article-title":"HMG-CoA reductase inhibitors induce apoptosis in pericytes","volume":"71","author":"Boucher","year":"2006","journal-title":"Microvasc Res"},{"key":"10.1016\/j.ajpath.2014.03.006_bib31","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1172\/JCI21378","article-title":"Semaphorin 3F, a chemorepulsant for endothelial cells, induces a poorly vascularized, encapsulated, nonmetastatic tumor phenotype","volume":"114","author":"Bielenberg","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajpath.2014.03.006_bib32","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/0005-2760(79)90028-6","article-title":"Effects of ML-236B on cholesterol metabolism in mice and rats: lack of hypocholesterolemic activity in normal animals","volume":"575","author":"Endo","year":"1979","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.ajpath.2014.03.006_bib33","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1074\/jbc.R100057200","article-title":"Control of cholesterol turnover in the mouse","volume":"277","author":"Dietschy","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2014.03.006_bib34","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/BF01745510","article-title":"Chemistry, biochemistry, and pharmacology of HMG-CoA reductase inhibitors","volume":"66","author":"Endo","year":"1988","journal-title":"Klin Wochenschr"},{"key":"10.1016\/j.ajpath.2014.03.006_bib35","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1002\/hep.21380","article-title":"Plasma cholesterol is hyperresponsive to statin in ABCG5\/ABCG8 transgenic mice","volume":"44","author":"Tang","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2014.03.006_bib36","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1126\/science.1093131","article-title":"Niemann-Pick C1 like 1 protein is critical for intestinal cholesterol absorption","volume":"303","author":"Altmann","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.ajpath.2014.03.006_bib37","doi-asserted-by":"crossref","first-page":"33586","DOI":"10.1074\/jbc.M405817200","article-title":"Niemann-Pick C1 like 1 (NPC1L1) is the intestinal phytosterol and cholesterol transporter and a key modulator of whole-body cholesterol homeostasis","volume":"279","author":"Davis","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2014.03.006_bib38","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0195-668X(02)00807-2","article-title":"Effects of ezetimibe, a new cholesterol absorption inhibitor, on plasma lipids in patients with primary hypercholesterolemia","volume":"24","author":"Knopp","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ajpath.2014.03.006_bib39","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1146\/annurev-physiol-012110-142233","article-title":"Niemann-pick C1-like 1 (NPC1L1) protein in intestinal and hepatic cholesterol transport","volume":"73","author":"Jia","year":"2011","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.ajpath.2014.03.006_bib40","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1161\/01.ATV.19.8.1938","article-title":"Hyperlipidemia and atherosclerotic lesion development in LDL receptor-deficient mice fed defined semipurified diets with and without cholate","volume":"19","author":"Lichtman","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ajpath.2014.03.006_bib41","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1359\/jbmr.2001.16.1.182","article-title":"Atherogenic high-fat diet reduces bone mineralization in mice","volume":"16","author":"Parhami","year":"2001","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ajpath.2014.03.006_bib42","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/pros.20683","article-title":"Carbohydrate restriction, prostate cancer growth, and the insulin-like growth factor axis","volume":"68","author":"Freedland","year":"2008","journal-title":"Prostate"},{"key":"10.1016\/j.ajpath.2014.03.006_bib43","doi-asserted-by":"crossref","first-page":"5390","DOI":"10.1158\/1078-0432.CCR-04-2391","article-title":"The matrix metalloproteinase-9\/neutrophil gelatinase-associated lipocalin complex plays a role in breast tumor growth and is present in the urine of breast cancer patients","volume":"11","author":"Fernandez","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ajpath.2014.03.006_bib44","doi-asserted-by":"crossref","first-page":"41886","DOI":"10.1074\/jbc.M110.166439","article-title":"The anti-angiogenic peptide, loop 6, binds insulin-like growth factor-1 receptor","volume":"285","author":"Fernandez","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2014.03.006_bib45","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1215\/S1152851705000232","article-title":"The role of pericytes in blood-vessel formation and maintenance","volume":"7","author":"Bergers","year":"2005","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ajpath.2014.03.006_bib46","first-page":"279","article-title":"Prostatic cholesterol metabolism: regulation and alteration","volume":"75A","author":"Schaffner","year":"1981","journal-title":"Prog Clin Biol Res"},{"key":"10.1016\/j.ajpath.2014.03.006_bib47","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1006\/bbrc.1993.1299","article-title":"The mouse low density lipoprotein receptor gene: cDNA sequence and exon-intron structure","volume":"191","author":"Hoffer","year":"1993","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ajpath.2014.03.006_bib48","first-page":"3842","article-title":"Low-density lipoprotein as a carrier of antitumoral drugs: in\u00a0vivo fate of drug-human low-density lipoprotein complexes in mice","volume":"46","author":"Masquelier","year":"1986","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2014.03.006_bib49","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1161\/01.ATV.6.2.178","article-title":"Conservation of the low density lipoprotein receptor-binding domain of apoprotein B: demonstration by a new monoclonal antibody, MB47","volume":"6","author":"Young","year":"1986","journal-title":"Arteriosclerosis"},{"key":"10.1016\/j.ajpath.2014.03.006_bib50","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1001\/jama.291.18.2243","article-title":"Drug treatment of hyperlipidemia in women","volume":"291","author":"Walsh","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.ajpath.2014.03.006_bib51","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1158\/1055-9965.EPI-07-0197","article-title":"Statin use and risk of prostate cancer in the California Men's Health Study Cohort","volume":"16","author":"Flick","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ajpath.2014.03.006_bib52","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1093\/jnci\/djj499","article-title":"Statin drugs and risk of advanced prostate cancer","volume":"98","author":"Platz","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ajpath.2014.03.006_bib53","unstructured":"US Department of Health and Human Services. Health, United States, 2010: with special feature on death and dying. Hyattsville (MD): National Center for Health Statistics (US). DHHS Pub No. 2011-1232. Available from: US Government Printing Office, Washington, DC; 76-641496"},{"key":"10.1016\/j.ajpath.2014.03.006_bib54","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1245\/s10434-013-3260-7","article-title":"Androgen receptor-positive triple negative breast cancer: a unique breast cancer subtype","volume":"21","author":"McGhan","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ajpath.2014.03.006_bib55","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1126\/science.1241908","article-title":"27-Hydroxycholesterol links hypercholesterolemia and breast cancer pathophysiology","volume":"342","author":"Nelson","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.ajpath.2014.03.006_bib56","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1161\/CIRCULATIONAHA.108.823740","article-title":"Functional role of CD11c+ monocytes in atherogenesis associated with hypercholesterolemia","volume":"119","author":"Wu","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.ajpath.2014.03.006_bib57","first-page":"4625","article-title":"Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma","volume":"56","author":"Leek","year":"1996","journal-title":"Cancer Res"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944014002144?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944014002144?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,3]],"date-time":"2018-10-03T03:26:46Z","timestamp":1538537206000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944014002144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":57,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S0002944014002144"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2014.03.006","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]}}}